Fairfax Financial Holdings’s Pacific Biosciences PACB Stock Holding History

Fairfax Financial Holdings’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-160,000	Closed	-$550K	–	62
2020 Q2	$550K	Hold	160,000	–	–	0.03%	54
2020 Q1	$490K	Hold	160,000	–	–	0.03%	48
2019 Q4	$822K	Hold	160,000	–	–	0.03%	37
2019 Q3	$824K	Hold	160,000	–	–	0.04%	30
2019 Q2	$966K	Hold	160,000	–	–	0.04%	31
2019 Q1	$1.16M	Hold	160,000	–	–	0.05%	29
2018 Q4	$1.18M	Buy	+160,000	New	+$1.01M	0.07%	27

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Fairfax Financial Holdings's PACB Position: Q3 2020 in Review

Fairfax Financial Holdings sold out of Pacific Biosciences (PACB) in Q3 2020, closing a stake of 160,000 shares — an estimated $550K sold.

Fairfax Financial Holdings first reported a position in PACB in Q4 2018 and held it in 7 quarters. The position peaked at $1.18M in Q4 2018. 174 funds tracked by Wall St. Rank hold PACB as of Q3 2020.

Fairfax Financial Holdings reported no remaining Pacific Biosciences position as of Q3 2020 after selling out during the quarter.
Fairfax Financial Holdings sold 160,000 Pacific Biosciences shares in Q3 2020, an estimated $550K.
Fairfax Financial Holdings first reported a position in Pacific Biosciences in Q4 2018 and held it in 7 quarters.
Fairfax Financial Holdings's Pacific Biosciences position peaked at $1.18M in Q4 2018.
174 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2020.

Based on Fairfax Financial Holdings's 13F filing for Q3 2020, filed 13 Nov 2020.